Get the content you want anytime you want.
REGISTER NOW | SIGN IN

C Diff Foundation

C Diff Foundation
The C Diff Foundation,is a 501(c) (3) non-profit organization, established in 2012, and comprised of 100% volunteering professionals dedicated at supporting public health through education and advocating for C. difficile infection (CDI) prevention, treatments, environmental safety, and support worldwide.

Latest Partner Content

Contaminated Hospital Mattresses Act as Vector for Drug-Resistant Infections
Edmond Hooker, MD, DrPH, discusses how contaminated hospital mattresses act as a vector for spreading drug-resistant infections.
Ridinilazole Shows Superior Efficacy for Treatment of <i>C. diff</i> in Phase 2 Study
Dr. Richard Vickers, discusses how ridinilazole showed superior efficacy for the treatment of C. diff when compared with vancomycin in a phase 2 study.
Preparing to Ensure Effective Stock & Delivery of Future <i>C. diff</i> Vaccine
Richard Haupt, MD, MPH, discusses what is needed to ensure that a future C. diff vaccine is adequately stocked and delivered to wherever individuals show up for vaccination.
Current Guidance for <i>C. diff</i> Disinfection in Health Care Facilities
Barley Chironda, RPN, CIC, discusses current guidance for disinfection practices against C. diff.
Cost-Benefit of Investing in Launderable Mattress Covers to Prevent CDIs
Edmond Hooker, MD, DrPH, discusses the cost benefit of investing in launderable hospital mattress covers to prevent CDIs.
Top Infectious Disease News of the Week—January 7, 2018
In case you missed them, we've compiled the top 5 articles from this past week.
How Does Ridinilazole Compare with Other Antibiotics That Target <i>C. diff</i>?
Dr. Richard Vickers, explains how ridinilazole is unique in its spectrum of activity compared with other antibiotics that target C. diff and have been approved or are in development.
Addressing the Challenges of Implementing Delivery of Future <i>C. diff</i> Vaccine
Richard Haupt, MD, MPH, discusses what would be required to adequately implement the delivery of a future C. diff vaccine.
FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.